Department of… Department of… Research Klinische Studien Systemic…

Systemic neuroscience

Neuromuscular studies

SpecialisationSystemic neurosciences (neuromuscular diseases)
IndicationHereditary transthyretin-mediated amyloid polyneuropathy
Short titleION-682884-CS13
Study titleExtension study to evaluate the long-term safety and efficacy of ION-682884 in patients with hereditary transthyretin-mediated amyloid polyneuropathy
Brief descriptionEvaluation of the long-term safety and efficacy of ION-682884 in patients with hereditary transthyretin-mediated amyloid polyneuropathy
PhaseIIIb
EudraCT-Number2021-001427-40
Statusfinalised
Contact

Study director: Prof Dr Markus Weiler

Phone: 06221-567504

E-mail: markus.weiler(at)med.uni-heidelberg.de

Study coordination: Sandra Schmich

Tel: 06221 56-37194

Fax: 06221 56-5935

E-mail: sandra.schmich(at)med.uni-heidelberg.de

SpecialisationSystemic neurosciences (neuromuscular diseases)
IndicationHereditary transthyretin amyloidosis
Short titleACT-EARLY (AG10-501)
Study titleA randomised, multicentre, double-blind, placebo-controlled phase III study for the prevention of transthyretin amyloidosis in young people with acoramidis
Brief descriptionA phase III, randomised, multicentre, double-blind, placebo-controlled trial for the prevention of transthyretin amyloidosis with acoramidis in people with a confirmed variant in the transthyretin gene.
PhasePHASE III
EudraCT-Number2024-513547-82
StatusOpen, recruitment from Q2 / 2025
Contact

Study management: Prof Dr Markus Weiler

Phone: 06221-567504

E-mail: markus.weiler(at)med.uni-heidelberg.de

Study coordination: Sandra Schmich

Tel: 06221 56-37194

Fax: 06221 56-5935

E-mail: sandra.schmich(at)med.uni-heidelberg.de

SpecialisationSystemic neurosciences (neuromuscular diseases)
Indication5q Spinal muscular atrophy
Short titleASCEND
Study titleStudy to evaluate higher dose nusinersen (BIIB058) in patients with spinal muscular atrophy previously treated with risdiplam
Brief descriptionEvaluation of higher dose nusinersen (BIIB058) in patients with spinal muscular atrophy previously treated with risdiplam
PhaseIIIb
EudraCT-Number2021-001294-23
StatusOpen, recruitment ongoing
Contact person

Study management: Prof Dr Markus Weiler

Phone: 06221-567504

E-mail: markus.weiler(at)med.uni-heidelberg.de

Study coordination: Sandra Schmich

Tel: 06221 56-37194

Fax: 06221 56-5935

E-mail: sandra.schmich(at)med.uni-heidelberg.de

SpecialisationSystemic neurosciences (neuromuscular diseases)
Indication5q Spinal muscular atrophy
Short titleSMArtCARE
Study titleFollow-up and therapy evaluation in spinal muscular atrophy
Short descriptionFollow-up and therapy evaluation in spinal muscular atrophy
Phasen. a.
EudraCT-Numbern. a.
StatusOpen, recruitment ongoing
Contact person

Study management: Prof Dr Markus Weiler

Phone: 06221-567504

E-mail: markus.weiler(at)med.uni-heidelberg.de

Study coordination: Sandra Schmich

Tel: 06221 56-37194

Fax: 06221 56-5935

E-mail: sandra.schmich(at)med.uni-heidelberg.de

SpecialisationSystemic neurosciences (neuromuscular diseases)
IndicationAmyotrophic lateral sclerosis (ALS) and other motor neurone diseases
Short titleEARLY-ALS
Study titleStudy to investigate early symptoms in patients with amyotrophic lateral sclerosis and other motor neurone diseases
Short descriptionInvestigation of early symptoms in patients with amyotrophic lateral sclerosis and other motor neurone diseases
Phasen.a.
EudraCT-Numbern.a.
StatusOpen, recruitment ongoing
Contact person

Study management: Prof Dr Markus Weiler

Phone: 06221-567504

E-mail: markus.weiler(at)med.uni-heidelberg.de

Study coordination: Sandra Schmich

Tel: 06221 56-37194

Fax: 06221 56-5935

E-mail: sandra.schmich(at)med.uni-heidelberg.de

SpecialisationSystemic neurosciences (neuromuscular diseases)
IndicationAmyotrophic lateral sclerosis (ALS) and other motor neurone diseases
Short titleTEAR-ALS
Study titleStudy to analyse biomarkers from tear fluid in patients with amyotrophic lateral sclerosis and other motor neuron diseases
Short descriptionAnalysis of biomarkers from tear fluid in patients with amyotrophic lateral sclerosis and other motor neurone diseases
Phasen.a.
EudraCT-Numbern.a.
StatusOpen, recruitment is ongoing.
Contact

Study director: Prof Dr Markus Weiler

Tel: 06221-567504

E-mail: markus.weiler(at)med.uni-heidelberg.de

Study coordination: Sandra Schmich

Tel: 06221 56-37194

Fax: 06221 56-5935

E-mail: sandra.schmich(at)med.uni-heidelberg.de

SpecialisationSystemic neurosciences (neuromuscular diseases)
IndicationAmyotrophic lateral sclerosis (ALS)
Study titleDeficits and potential for improvement in the psychosocial and palliative care of ALS patients in Germany
Brief descriptionMulticentre, questionnaire-based study to assess satisfaction with palliative, including psychosocial care for ALS patients in Germany
Phasen.a.
EudraCT-Numbern.a.
StatusOpen, recruitment is ongoing.
Contact

Study director: Prof Dr Markus Weiler

Phone: 06221-567504

E-mail: markus.weiler(at)med.uni-heidelberg.de

Study coordination: Sandra Schmich

Tel: 06221 56-37194

Fax: 06221 56-5935

E-mail: sandra.schmich(at)med.uni-heidelberg.de

EN